Summit Tx Capital, L.P. Astrazeneca PLC Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 7,662 shares of AZN stock, worth $653,645. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,662Holding current value
$653,645% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.43 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.51 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.93 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.68 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.66 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $264B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...